DOP Guide: Domestic DOP Market High Integration on July 10

DOP Guide: Yesterday, the domestic DOP market was consolidated at a high level and the trading atmosphere was cold. However, the high level of octanol and phthalic anhydride raw materials, leading to high cost support still exists, coupled with the DOP industry supply is not strong, still driving dimension prices, but the downstream demand has not improved, not only off-season constraints, more is to catch up with high risks, poor inquiries and procurement, aggravating wait-and-see attitude. The reference price of East China is 7600-7700 yuan per ton, the reference price of South China is 7650-7750 yuan per ton, and the reference price of North China is 7400-7600 yuan per ton. Future market forecast: new orders will still be limited, so under the game of cost and demand, DOP market is mostly high level consolidation.
2026-09-10
Trade Alert
Delivering the latest product trends and industry news straight to your inbox.
(We'll never share your email address with a third-party.)
Related News
-
Colombia Makes Preliminary Ruling in Anti-Dumping Investigation into Chinese DOP Imports
-
China DOP Import and Export Inventory in 2021
-
Market Analysis - Weekly Report - January 10th to January 14th, 2022- Hot Products
-
DOTP and DOP Price Gap Narrowed Substantially in 2021
-
The DOP Market is Falling Hard to Stop
-
Market Analysis - Weekly Report - November 8th to November 12th, 2021- Hot Products
-
Market Analysis- Weekly Report- October 01 to October 08, 2021- Hot Products
-
DOP imports increased and exports decreased in August 2021
-
Market Analysis- Weekly Report- August 2 to August 6, 2021- Hot Products
-
DOP Guide: on April 17, the focus of domestic DOP market fell
Recommend Reading
-
LG Chem Enters Semiconductor Stripper Market for the First Time, Cutting Process Time by 50%
-
FDA Approves Lantheus’ TAUKLARIFY for Alzheimer’s Tau PET Imaging
-
Private Equity Firm Acquires Lyons Magnus for About $1 Billion as Beverage and Nutrition Ingredients Consolidate
-
FDA Grants Accelerated Approval to Bristol Myers Squibb’s ZENBEXUS, Launching First CELMoD Therapy in Multiple Myeloma
-
Merck Wins Approval for the World’s First Oral PCSK9 Drug, with Potential Annual Sales of $5 Billion
-
Bullish Support Pushes Up January Adipic Acid Prices in China
-
Premium Global Chemical Sourcing Requests (23 - 27 Feb, 2026)
-
Business Society’s EVA Market Outlook on August 11, 2026: Short-Term Price Decline
-
Cost Support: Styrene-butadiene rubber market prices rise sharply
-
Business Society’s Market Outlook for MIBK on August 11, 2026: Tending to Weak